Cephalosporin
drugOn this page
Summary
Cephalosporin (CHEMBL5482975) is a phase-3 clinical-stage unknown; indicated across 2 conditions including pneumonia.
At a glance
- Status: Max clinical phase 3 (not approved)
- Modality: Unknown
- Indications: 2 conditions
- Clinical trials: 10
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL5482975 |
| Name | Cephalosporin |
| Type | Unknown |
| Max phase | 3 |
Also known as: Cephalosporin, cephalosporin, CEPHALOSPORIN
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
2 indications (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).
| Indication | Trial phase | MONDO | EFO |
|---|---|---|---|
| pneumonia | 3 | MONDO:0005249 | EFO:0003106 |
1 further indication record had no mapped disease name (EFO/MeSH-only) or were duplicates, and are omitted.
Clinical trials
Total trials: 10.
Phase distribution
| Phase | Trials |
|---|---|
| Not specified | 5 |
| PHASE4 | 4 |
| PHASE3 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT02913118 | PHASE4 | UNKNOWN | Adjunctive Therapy of Andrographolid Sulfonatein Community Acquired Pneumonia |
| NCT04062175 | PHASE4 | COMPLETED | Efficacy of Adding Azithromycin to Cephalosporin Before Cesarean Delivery |
| NCT04401553 | PHASE4 | WITHDRAWN | Prophylactic Antibiotics for Surgical Site Infections and Beta-Lactam Allergy |
| NCT05094154 | PHASE4 | COMPLETED | Effect of Antibiotic Choice On ReNal Outcomes (ACORN) |
| NCT05267977 | PHASE3 | WITHDRAWN | Antibiotic Use & Open Fracture of the Lower Extremity |
| NCT07442357 | Not specified | NOT_YET_RECRUITING | The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial |
| NCT01750385 | Not specified | UNKNOWN | Bacteremia and Procalcitonin Levels in Peroral Endoscopic Myotomy for Achalasia |
| NCT02314013 | Not specified | UNKNOWN | Randomized Clinical Trial for the Uncomplicated Diverticulitis in Right Colon |
| NCT02490293 | Not specified | COMPLETED | Is it Fair to Use Antibiotics After Laparoscopic Cholecystectomy for the Patients With Acutely Inflamed Gallbladder? |
| NCT03917134 | Not specified | UNKNOWN | Prevention of Vaginal Cellulitis or Vaginal Cuff Abscess After Laparoscopic Hysterectomy |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
- Diseases: pneumonia